USE OF STING AGONISTS TO TREAT VIRALLY-INDUCED AND PRE-MALIGNANT GROWTHS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Feb 22, 2017
filing date -
Feb 23, 2016
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Disclosed herein are methods of treating or inhibiting a pre-malignant condition, a benign neoplasia, or a virally-induced growth in a subject. The methods include administering a composition including an effective amount of one or more Stimulator of Interferon Genes (STING) agonists, or a pharmaceutically acceptable salt or prodrug thereof, to the subject. In particular embodiments, the methods include administering one or more STING agonists that are a cyclic dinucleotide or a derivative thereof to the subject, for example cyclic diadenylate monophosphate, cyclic diguanylate monophosphate, or a derivative thereof.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully